Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783715 · ClinicalTrials.gov registry record
Characterization of Treatment Responses in Lymphedema
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03783715: Clinical Trial study, sponsored by Stanford University.
NCT03783715 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03783715 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This study is designed to investigate the treatment response of lymphedema, of the upper or lower extremity, during clinical, pharmacologic treatment of lymphedema with oral ketoprofen. Correlation of clinical responses (changes in limb volume and skin thickness) with changes in the inflammasome will help to define the molecular substrate of treatment response.
Interventions
- DRUG Ketoprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-06-21 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03783715
The ClinicalTrials.gov registry entry for NCT03783715 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketoprofen is the first listed.
NCT03783715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03783715 about?
NCT03783715 is a clinical study titled "Characterization of Treatment Responses in Lymphedema". This study is designed to investigate the treatment response of lymphedema, of the upper or lower extremity, during clinical, pharmacologic treatment of lymphedema with oral ketoprofen. Correlation of clinical responses (changes in limb volume and skin thickness) with changes in the inflammasome wil...
What is the current status of trial NCT03783715?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-06-21. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT03783715?
The interventions under investigation include: Ketoprofen (DRUG).
Who is sponsoring clinical trial NCT03783715?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.